For one in five drugs, dosages are ultimately lowered years after FDA approval—after millions of people have received the higher doses. [More]
- Wood A.J.J. “The safety of new medicines. The importance of asking the right questions” JAMA editorial, 281 (1999):1753-1754.
- Cohen, J.S. Over Dose: The Case Against the Drug Companies: Prescription Drugs, Side Effects, and Your Health. New York: Penguin Putnam Inc., 2001.
- Strand, R.D. Death by Prescription: The Shocking Truth Behind an Overmedicated Nation. Nashville: Thomas Nelson Publishers, 2003.
- Lazarou J., et al. “Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.” JAMA 279 (1998):1200-1205.
- Sharav, V.H. “Conflicts of Interest,” 14th Tri-Service Clinical Investigation Symposium sponsored by U.S. Army Medical Department and The Henry M. Jackson Foundation for The Advancement of Military Medicine (May 6-8, 2002): psychrights.org/Drugs/AllenJonesTMAPJanuary20.pdf.
- Temple, R.T., et al. “Safety of newly approved drugs; Implications for prescribing,” JAMA editorial, 287 (2002):2273.
- Willman, D. “How a New Policy Led to Seven Deadly Drugs,” Los Angeles Times, Dec. 20, 2000 (front page).